1 Introduction
The novel coronavirus disease (COVID‐19), which is associated with
significant morbidity and medical complications induced by SARS- CoV-2,
has rapidly spread sparking alarm worldwide.1,2 In
June 2020 WHO declared COVID-19 as global pandemic which has made many
countries to shut down their borders3. Asthma has
become the most common chronic respiratory disease in
children4-6. As is well known to all for many decades,
respiratory infections trigger asthma exacerbations7.
Studies had reported that patients with asthma would experience
increased asthma-associated morbidity because of the respiratory virus
SARS-CoV-2 infection, based on experience with other respiratory viral
infections8,9. However, some studies suggested that
there was no apparent increase in asthma related morbidity in children
with asthma10, it is even possible that due to reduced
exposures due to confinement, such children may have improved
outcomes11.
The main objective of this study was to identify how is the asthma in
children during the COVID-19 pandemic controlled compared with the time
before it.